Crizotinib and Vorasidenib: Interaction Details

Brand names
Crizotinib
Xalkori
Vorasidenib
Voranigo
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Vorasidenib

Brand name
  • Voranigo

We don't have a drug information page for Vorasidenib yet. Have a question about Vorasidenib? Ask a pharmacist, free →

What Happens When You Take Crizotinib With Vorasidenib

What can happen when they are taken together (rated Major)

Reduced with NTI exposure and reduced of CYP3A substrate with NTI

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Vorasidenib, which induces , should not be given together with a CYP3A substrate that has a (NTI). Exposure to CYP3A substrates may fall with vorasidenib, and for these drugs even small shifts in concentration can result in diminished efficacy. Repeated dosing of vorasidenib alongside CYP3A substrates is predicted to lower the concentrations of those substrates.1

The Crizotinib and Vorasidenib Interaction, Explained

Vorasidenib can lower the amount of crizotinib in your body. Vorasidenib speeds up a liver enzyme () that helps break down crizotinib. With more of it cleared faster, crizotinib may not work as well as intended against your cancer.

This is a major interaction, and the evidence for it is considered probable. Please do not change or stop either medicine on your own. Tell your pharmacist and your prescriber that you take both, since your care team can review your options and decide on the safest plan for you.

Mechanism: Vorasidenib is a . Crizotinib is a CYP3A4 , and its exposure is predicted to fall with multiple-dose vorasidenib (PK interaction, reduced and ).

  • Direction: decreased crizotinib concentrations, with possible loss of . Crizotinib is not a , so reduced exposure means reduced effect.
  • Labeling: avoid of vorasidenib with substrates where minimal concentration changes may reduce efficacy.
  • Evidence: probable, largely predicted from the inducer mechanism. Onset unspecified.
  • Management: avoid the combination where possible. If it cannot be avoided, individualize therapy and monitor closely for reduced response.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Crizotinib and Vorasidenib Interact

The likely mechanism

of -substrate by vorasidenib

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Crizotinib and Vorasidenib Interaction

The documented advice is to avoid using these two medicines together, because vorasidenib may lower crizotinib levels and reduce how well it works.

  • Keep taking both exactly as prescribed until your care team tells you otherwise.
  • Make sure your prescriber and pharmacist know you take both medicines.
  • Ask whether an alternative is appropriate, or whether your plan may need to be adjusted and individualized by your care team.
  • Your team may monitor you more closely for how well your treatment is working.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Crizotinib or Vorasidenib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: VORANIGO oral tablets, vorasidenib oral tablets

    of multiple doses of vorasidenib with is predicted to lower the concentrations of those substrates.1

Crizotinib and Vorasidenib: Common Questions

How serious is the Crizotinib and Vorasidenib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Crizotinib and Vorasidenib interaction managed?

The documented advice is to avoid using these two medicines together, because vorasidenib may lower crizotinib levels and reduce how well it works. Keep taking both exactly as prescribed until your care team tells you otherwise. Make sure your prescriber and pharmacist know you take both medicines. Ask whether an alternative is appropriate, or whether your plan may need to be adjusted and individu… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Crizotinib and Vorasidenib Interaction

Ask in your own words about taking Crizotinib and Vorasidenib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VORANIGO® oral tablets, vorasidenib oral tablets. Servier Pharmaceuticals LLC (per FDA), Boston, MA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Crizotinib and Vorasidenib

Also serious with Crizotinib

Also serious with Vorasidenib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Crizotinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.